Biosciences
-
SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence
Companies will combine SynFini and Centaur Chemist platforms to focus on small-molecule oncology target.
-
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
Researchers will utilize Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to discover new compounds against multiple viruses, including the coronavirus (COVID-19).
-
SRI Introduces Novel Synthetic Chemistry System at SLAS 2020
SRI Biosciences Chief Strategy Officer Nathan Collins, Ph.D., will present an overview of SynFini, the company’s fully automated, end-to-end synthetic-chemistry system.
-
If better sleep is part of your New Year’s resolution, check out this study from SRI researchers about the usefulness of a fitness watch for sleep tracking
-
Research Shows Fitness Watch Can Accurately Track Sleep Patterns
Results from first study comparing consumer sleep tracker against research-grade tracker over two weeks in home environment published in Journal of Sleep.
-
The brain may actively forget during dream sleep
In this study, scientists looked at neighboring cells that produce melanin concentrating hormone, a molecule known to be involved in the control of both sleep and appetite.
-
Handwriting recognition, signature verification and pen-input computing
How they know your online you is really you.